EDP Sciences logo
Web of Conferences logo
Search
Menu
All issues Volume 391 (2023) E3S Web Conf., 391 (2023) 01133 References
Open Access
Issue
E3S Web Conf.
Volume 391, 2023
4th International Conference on Design and Manufacturing Aspects for Sustainable Energy (ICMED-ICMPC 2023)
Article Number 01133
Number of page(s) 17
DOI https://doi.org/10.1051/e3sconf/202339101133
Published online 05 June 2023
  1. Andreu, Z., & Yáñez-Mó, M. (2014). Tetraspanins in extracellular vesicle formation and function. Frontiers in immunology, 5, 442. [CrossRef] [PubMed] [Google Scholar]
  2. Arslan, F., Lai, R. C., Smeets, M. B., Akeroyd, L., Choo, A., Aguor, E. N., Timmers, L., van Rijen, H. V., Doevendans, P. A., Pasterkamp, G., Lim, S. K., & de Kleijn, D. P. (2013). Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem cell research, 10(3), 301–312. [CrossRef] [PubMed] [Google Scholar]
  3. Asadirad, A., Yarahmadi, M., Abbasi, M., Sadeghizadeh, M., & Najafi, F. (2020). Exosomes: a new therapeutic approach to cancer therapy. Journal of cellular physiology, 235(4), 3324–3335. [Google Scholar]
  4. Babashah, S., & Soleimani, M. (2013). The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. European journal of cancer, 49(11), 3458–3466. [Google Scholar]
  5. Bae, S., Brumbaugh, J., & Bonavida, B. (2021). Exosomes derived from cancer cells as potential targets for cancer immunotherapy: a review. Cancer immunology, immunotherapy, 70(3), 441–449. [Google Scholar]
  6. Barile, L., Vassalli, G., & Moccetti, T. (2017). Exosomes: therapy delivery tools and biomarkers of diseases. Pharmacology & therapeutics, 174, 63–78. [CrossRef] [PubMed] [Google Scholar]
  7. Belting, M., Christianson, H. C., & Svensson, K. J. (2012). Exosomes and membrane microparticles in tumor biology: diagnostic and therapeutic implications. Journal of internal medicine, 276(6), 529–541. [Google Scholar]
  8. Beninson, L. A., Brown, P. N., Loughner, M., & Saludes, J. P. (2020). Nanoscale forces and their impact on protein and lipid organization in cell membranes. Chemical Society Reviews, 49(8), 2378–2391. [CrossRef] [PubMed] [Google Scholar]
  9. Berchem, G., Noman, M. Z., Bosseler, M., Paggetti, J., Baconnais, S., Le Cam, E., Nanbakhsh, A., Moussay, E., Mami-Chouaib, F., & Janji, B. (2016). Hypoxic tumor- derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-ß and miR23a transfer. Oncoimmunology, 5(4), e1062968. [CrossRef] [PubMed] [Google Scholar]
  10. Boelens, M. C., Wu, T. J., Nabet, B. Y., Xu, B., Qiu, Y., Yoon, T., Azzam, D. J., Twyman-Saint Victor, C., Wiemann, B. Z., Ishwaran, H., Ter Brugge, P., Jonkers, J., Slingerland, J. [Google Scholar]
  11. Boukouris, S., & Mathivanan, S. (2015). Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteomics, 15(16), 2628–2641. [Google Scholar]
  12. Cai, Z., Yang, F., Yu, L., Yu, Z., Jiang, L., Wang, Q., Yang, Y., Wang, L., Cui, Y., Zhu, Y., & Zhang, J. (2019). Activated T cell exosomes promote tumor invasion via Fas signaling pathway. Journal of immunology, 203(2), 375–383. [Google Scholar]
  13. Calin, G. A., & Croce, C. M. (2006). MicroRNA signatures in human cancers. Nature reviews cancer, 6(11), 857–866. [CrossRef] [PubMed] [Google Scholar]
  14. Cappello, F., Logozzi, M., Campanella, C., Bavisotto, C. C., Marcilla, A., Properzi, F., Fais, S., & Exosome Committee. (2017). Exosomes and their role in the microenvironment: a therapeutic strategy for cancer. Journal of cellular physiology, 232(7), 1660–1668. [CrossRef] [PubMed] [Google Scholar]
  15. Cha, D. J., Franklin, J. L., Dou, Y., Liu, Q., Higginbotham, J. N., Demory Beckler, M., Weaver, A. M., Vickers, K. C., Prasad, N., Levy, S., Zhang, B., Coffey, R. J., & Patton, J. G. (2015). KRAS-dependent sorting of miRNA to exosomes. Elife, 4, e07197. [CrossRef] [PubMed] [Google Scholar]
  16. Chen, G., Huang, A. C., Zhang, W., Zhang, G., Wu, M., Xu, W., Yu, Z., Yang, J., Wang, B., Sun, H., Xia, H., Man, Q., Zhong, W., Antelo, L. F., Wu, Q., Xiong, X., Liu, X., Guan, L., Li, T., … Ye, Y. (2018). Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature, 560(7718), 382–386. [CrossRef] [PubMed] [Google Scholar]
  17. Chen, W. X., Liu, X. M., Lv, M. M., Chen, L., Zhao, J. H., & Zhong, S. L. (2014). Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PloS one, 9(4), e95240. [CrossRef] [PubMed] [Google Scholar]
  18. Chen, X., Liang, H., Zhang, J., Zen, K., & Zhang, C. Y. (2012). Horizontal transfer of microRNAs: molecular mechanisms and clinical applications. Protein & cell, 3(1), 28–37. [CrossRef] [PubMed] [Google Scholar]
  19. Colombo, M., Raposo, G., & Théry, C. (2014). Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annual review of cell and developmental biology, 30, 255–289. [CrossRef] [PubMed] [Google Scholar]
  20. Corcoran, C., Rani, S., O’Brien, K., O’Neill, A., Prencipe, M., Sheikh, R., Webb, G., McDermott, R., Watson, W., & Crown, J. (2012). Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via ex [Google Scholar]
  21. Costa-Silva, B., Aiello, N. M., Ocean, A. J., Singh, S., Zhang, H., Thakur, B. K., Becker, A., Hoshino, A., Mark, M. T., Molina, H., Xiang, J., Zhang, T., Theilen, T. M., García-Santos, G., Williams, C., Ararso, Y., Huang, Y., Rodrigues, G., … Lyden, D. (2015). Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nature cell biology, 17(6), 816–826. [CrossRef] [PubMed] [Google Scholar]
  22. Crescitelli, R., Lässer, C., Szabó, T. G., Kittel, A., Eldh, M., Dianzani, I., Buzás, E. I., Lötvall, J., & Valadi, H. (2013). Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. Journal of extracellular vesicles, 2(1), 20677. [CrossRef] [Google Scholar]
  23. De Palma, M., & Lewis, C. E. (2013). Macrophage regulation of tumor responses to anticancer therapies. Cancer cell, 23(3), 277–286. [CrossRef] [PubMed] [Google Scholar]
  24. Delorme-Axford, E., Donker, R. B., Mouillet, J. F., Chu, T., Bayer, A., Ouyang, Y., Wang, T., Stolz, D. B., Sarkar, S. N., & Morelli, A. E. (2013). Human placental trophoblasts confer viral resistance to recipient cells. Proceedings of the National Academy of Sciences, 110(29), 12048–12053. [CrossRef] [PubMed] [Google Scholar]
  25. Duijvesz, D., Burnum-Johnson, K. E., Gritsenko, M. A., Hoogland, A. M., Vredenbregt-van den Berg, M. S., Willemsen, R., Luider, T. M., Pasa-Tolić, L., Jenster, G., & Quantitative Clinical Proteomics Study Group. (2013). Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer. PloS one, 8(12), e82589. [CrossRef] [PubMed] [Google Scholar]
  26. Fan, J., Wei, Q., & Koay, E. J. (2020). Extracellular vesicles in cancer: exosomes, microvesicles, and the emerging role of large oncosomes. Journal of molecular medicine, 98(2), 153–166. [Google Scholar]
  27. Fong, M. Y., Zhou, W., Liu, L., Alontaga, A. Y., Chandra, M., Ashby, J., Chow, A., O’Connor, S. T., Li, S., Chin, A. R., Somlo, G., Palomares, M., Li, Z., Tremblay, J. R., Tsuyada, A., Sun, G., Reid, M. D., Wu, X., Swiderski, P., … Lai, C. K. (2015). Breast- cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nature cell biology, 17(2), 183–194. [CrossRef] [PubMed] [Google Scholar]
  28. Gao, X., Ran, N., Dong, X., Zuo, B., Yang, R., Zhou, Q., Moulton, H. M., & Seow, Y. (2019). A novel exosome-bound super-enhancer promotes cancer progression in liver cancer. Theranostics, 9(26), 7695–7711. [Google Scholar]
  29. Gernapudi, R., Yao, Y., Zhang, Y., Wolfson, B., Roy, S., Duru, N., & Kapoor, V. (2015). Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer. Breast cancer research and treatment, 150(3), 685–695. [CrossRef] [PubMed] [Google Scholar]
  30. Greening, D. W., Gopal, S. K., Xu, R., Simpson, R. J., & Chen, W. (2015). Exosomes and their roles in immune regulation and cancer. Seminars in cell & developmental biology, 40, 72–81. [CrossRef] [PubMed] [Google Scholar]
  31. Guo, D., & Chen, Y. (2020). Exosomes: a new player in cancer immunity. Oncology letters, 19(6), 3949–3955. [Google Scholar]
  32. Guo, F., Wang, Q., Liu, C., & Wu, H. (2019). Exosomes: key players in cancer and potential therapeutic strategies. Signal transduction and targeted therapy, 4(1), 1–18. [CrossRef] [PubMed] [Google Scholar]
  33. Hannafon, B. N., Trigoso, Y. D., Calloway, C. L., Zhao, Y. D., Lum, D. H., Welm, A. L., Zhao, Z. J., & Blick, K. E. (2016). Plasma exosome microRNAs are indicative of breast cancer. Breast cancer research, 18(1), 90. [CrossRef] [PubMed] [Google Scholar]
  34. He, M., Qin, H., Poon, T. C., Sze, S. C., Ding, X., Co, N. N., Ngai, S. M., Chan, T. F., Wong, N., & Ng, I. O. (2015). Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs. Carcinogenesis, 36(8), 1008–1018. [CrossRef] [PubMed] [Google Scholar]
  35. Henne, W. M., Buchkovich, N. J., & Emr, S. D. (2011). The ESCRT pathway. Developmental cell, 21(1), 77–91. [CrossRef] [PubMed] [Google Scholar]
  36. Hoshino, A., Costa-Silva, B., Shen, T. L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., Singh, S., Williams, C., Soplop, N., Uryu, K., Pharmer, L., King, T., Bojmar, L., Davies, A. E., Ararso, … Lyden, D. (2015). Tumour exosome integrins determine organotropic metastasis. Nature, 527(7578), 329–335. [CrossRef] [PubMed] [Google Scholar]
  37. Hu, Q., Cai, J., & Yan, L. (2019). Exosome and active targeting drug delivery systems: a new intelligent treatment system. Journal of nanobiotechnology, 17(1), 1–20. [CrossRef] [PubMed] [Google Scholar]
  38. Jaiswal, R., Sedger, L. M., & McDevitt, H. (2019). Role of soluble factors in the modification of tumor cell-derived exosomes. Cancer research, 79(11), 2798–2807. [PubMed] [Google Scholar]
  39. Jiang, L., Zhang, S., Hu, H., Yang, J., Wang, X., Ma, Y., Wu, P., & Hu, G. (2020). Exosomes in pathogenesis, diagnosis, and treatment of Alzheimer’ s disease. MedComm, 1(1), 20–33. [Google Scholar]
  40. Kahlert, C., Kalluri, R., & Exosomes in Tumor Microenvironment. (2013). The Journal of cancer research, 19(17), 5127–5133. [Google Scholar]
  41. Kalra, H., Simpson, R. J., Ji, H., Aikawa, E., Altevogt, P., Askenase, P., Bond, V. C., Borràs, F. E., Breakefield, X., Budnik, V., Buzas, E., Camussi, G., Clayton, A., Cocucci, E., Falcon-Perez, J. M., Gabrielsson, S., Gho, Y. S., Gupta, D., Harsha, H. C.,. Mathivanan, S. (2012). Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PloS biology, 10(12), e1001450. [CrossRef] [PubMed] [Google Scholar]
  42. Kalluri, R. (2016). The biology and function of exosomes in cancer. The Journal of clinical investigation, 126(4), 1208–1215. [CrossRef] [PubMed] [Google Scholar]
  43. Kalluri, R., & LeBleu, V. S. (2020). The biology, function, and biomedical applications of exosomes. Science, 367(6478), eaau6977. [CrossRef] [PubMed] [Google Scholar]
  44. Khan, S., Jutzy, J. M. S., Aspe, J. R., McGregor, D. W., Neidigh, J. W., & Wall, N. R. (2011). Survivin is released from cancer cells via exosomes. Apoptosis, 16(1), 1–12. [CrossRef] [PubMed] [Google Scholar]
  45. Kim, J. W., Wieckowski, E., Taylor, D. D., Reichert, T. E., & Watkins, S. (2005). Whiteside TL Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clinical cancer research, 11(3), 1010–1020. [CrossRef] [PubMed] [Google Scholar]
  46. Kim, D. H., Kim, H., Choi, Y. J., Kim, S. Y., Lee, J. E., Sung, K. J., Lim, D. H., Kim, K. H., & Kim, S. H. (2013). Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer. Experimental & molecular medicine, 45(12), e61–e61. [CrossRef] [PubMed] [Google Scholar]
  47. Koga, Y., Yasunaga, M., Moriya, Y., Akasu, T., Fujita, S., Yamamoto, S., Matsumura, Y., & Oncol, T. (2011). Exosome can prevent RNase from degrading microRNA in feces. Journal of gastrointestinal oncology, 2(4), 215–222. [PubMed] [Google Scholar]
  48. Koppers-Lalic, D., Hogenboom, M. M., Middeldorp, J. M., & Pegtel, D. M. (2013). Virus-modified exosomes for targeted RNA delivery; a new approach in nanomedicine. Advanced drug delivery reviews, 65(3), 348–356. [CrossRef] [PubMed] [Google Scholar]
  49. Li, B., Lu, Y., Wang, H., Han, X., Mao, J., Li, J., Yu, Y., Wang, B., Yang, Z., Zhang, Z., Yu, X., & Zhao, Y. (2018). Exosomes derived from human adipose mesenchymal stem cells promote breast cancer metastasis by delivering miR-140-5p. Aging, 10(11), 3241–3257. [Google Scholar]
  50. Li, I., Nabet, B. Y., & Exosomes in the tumor microenvironment as mediators of cancer therapy resistance. (2019). Molecular cancer, 18(1), 1–14. [PubMed] [Google Scholar]
  51. Li, Y., & Wang, J. (2020). Extracellular vesicles-mediated signaling in prostate cancer progression. Journal of cancer metastasis and treatment, 6, 26. [Google Scholar]
  52. Li, Y., Wu, J., & Hu, X. (2019). Role of exosomal microRNAs in lung cancer pathogenesis and personalized medicine. Clinical and translational medicine, 8(1), 1–14. [PubMed] [Google Scholar]
  53. Théry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., … & Buzás, E. I. (2018). Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. Journal of extracellular vesicles, 7(1), 1535750. [CrossRef] [PubMed] [Google Scholar]
  54. Yáñez-Mó, M., Siljander, P. R. M., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., … & De Wever, O. (2015). Biological properties of extracellular vesicles and their physiological functions. Journal of extracellular vesicles, 4(1), 27066. [CrossRef] [PubMed] [Google Scholar]
  55. van Niel, G., D’Angelo, G., & Raposo, G. (2018). Shedding light on the cell biology of extracellular vesicles. Nature Reviews Molecular Cell Biology, 19(4), 213–228. [CrossRef] [PubMed] [Google Scholar]
  56. Liu, C., Yang, Y., Wu, Y., & Chen, X. (2018). Extracellular vesicles in lung cancer- From bench to bedside. Seminars in cell & developmental biology, 78, 128–131. [Google Scholar]
  57. Liu, Y., Gu, Y., Han, Y., Zhang, Q., Jiang, Z., Zhang, X., & Huang, B. (2020). Exosomes: a new pathway for tumor immunotherapy. Journal of immunology research, 2020. [Google Scholar]
  58. Ma, C., He, Y., & Liu, J. (2020). Exosomes in tumor microenvironment: novel transporters and biomarkers. Journal of translational medicine, 18(1), 1–20. [CrossRef] [PubMed] [Google Scholar]
  59. Maacha, S., Sidahmed, H., Jacob, S., Gentilhomme, O., & AlKhatib, A. (2019). Exosomes: secretion, nano-communication, and their potential therapeutic applications in cancer. Journal of cellular physiology, 234(6), 8219–8237. [Google Scholar]
  60. Maas, S. L. N., Breakefield, X. O., & Weaver, A. M. (2017). Extracellular vesicles: unique intercellular delivery vehicles. Trends in cell biology, 27(3), 172–188. [CrossRef] [PubMed] [Google Scholar]
  61. Maldonado-Báez, L., & Wendland, B. (2006). Endocytic adaptors: recruiters, coordinators and regulators. Trends in cell biology, 16(10), 505–513. [CrossRef] [PubMed] [Google Scholar]
  62. Mathieu, M., Martin-Jaular, L., Lavieu, G., & Théry, C. (2019). Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nature cell biology, 21(1), 9–17. [CrossRef] [PubMed] [Google Scholar]
  63. Melo, S. A., Luecke, L. B., Kahlert, C., Fernandez, A. F., Gammon, S. T., Kaye, J., LeBleu, V. S., Mittendorf, E. A., Weitz, J., Rahbari, N., Reissfelder, C., Pilarsky, C., Fraga, M. F., Piwnica-Worms, D., & Kalluri, R. (2015). Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature, 523(7559), 177–182. [CrossRef] [PubMed] [Google Scholar]
  64. Min, L., Shen, J., Tu, C., Hornicek, F., & Duan, Z. (2020). The roles and implications of exosomes in sarcoma. Cancer metastasis reviews, 39(1), 31–51. [Google Scholar]
  65. Mittelbrunn, M., & Sánchez-Madrid, F. (2012). Intercellular communication: diverse structures for exchange of genetic information. Nature reviews Molecular cell biology, 13(5), 328–335. [CrossRef] [PubMed] [Google Scholar]
  66. Munagala, R., Aqil, F., Jeyabalan, J., Gupta, R. C., & Bovine milk-derived exosomes for drug delivery. (2016). Cancer letters, 371(1), 48–61. [CrossRef] [PubMed] [Google Scholar]
  67. Nabet, B. Y., Qiu, Y., Shabason, J. E., Wu, T. J., Yoon, T., Kim, B. C., Benci, J. L., DeMichele, A. M., Tchou, J., Marcotrigiano, J., Nagle, J. M., Barrett, D., & Kimmelman, A. C. (2017). Exosome RNA unshielding couples stromal activation to pattern recognition receptor signaling in cancer. Cell, 170(2), 352–366. [CrossRef] [PubMed] [Google Scholar]
  68. Nandy, S. B., Mohanty, S., Singh, M., & Behari, S. (2021). Role of Exosomes and Exosomal microRNAs in Cancer Diagnosis and Treatment. Handbook of Experimental Pharmacology, 267, 271–290. [Google Scholar]
  69. Nazimek, K., Bryniarski, K., Askenase, P. W., & Bujnicki, J. M. (2018). Biological properties and characteristics of exosomes and their potential application in translational medicine. Postepy higieny i medycyny doswiadczalnej (Online), 72. [Google Scholar]
  70. Nojima, H., Freeman, C. M., & Schuster, R. M. (2018). J-curve relationship between alcohol consumption and systemic inflammation in US adults. Journal of studies on alcohol and drugs, 79(1), 57–63. [Google Scholar]
  71. O’Brien, K., Rani, S., Corcoran, C., Wallace, R., Hughes, L., Friel, A. M., McDonnell, S., Crown, J., Radomski, M. W., & O’Driscoll, L. (2013). Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells. European journal of cancer, 49(8), 1845–1859. [CrossRef] [PubMed] [Google Scholar]
  72. Ohno, S., Ishikawa, A., Kuroda, M., & Role of extracellular vesicles in autoimmune diseases. (2017). Clinical reviews in allergy & immunology, 52(2), 134–144. [Google Scholar]
  73. Ostenfeld, M. S., Jeppesen, D. K., Laurberg, J. R., Boysen, A. T., Bramsen, J. B., Primdal-Bengtson, B., & Lamy, P. (2016). Cellular disposal of miR23b by RAB27- dependent exosome release is linked to acquisition of metastatic properties. Cancer research, 76(16), 4671–4680. [CrossRef] [Google Scholar]
  74. Peinado, H., Alečkovic, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C., Nitadori-Hoshino, A., Hoffman, C., Badal, K., Garcia, B. A., Callahan, M. K., Yuan, J., Martins, V. R., Skog, J., … Lyden, D. (2012). Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nature medicine, 18(6), 883–891. [CrossRef] [PubMed] [Google Scholar]
  75. Qu, L., Ding, J., Chen, C., Wu, Z. J., Liu, B., Gao, Y., Chen, W., Liu, F., Sun, W., Li, X., Wang, X., Wang, Y., Xu, Z. Y., Li, Y., Fang, Z. Y., Xu, Z. D., & Bao, Y. (2016). Exosome-Transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer cell, 29(5), 653–668. [CrossRef] [PubMed] [Google Scholar]
  76. Reclusa, P., Taverna, S., Pucci, M., & Durendez, E. G. (2018). Exosome-based therapeutics in cancer: current status and future directions. Journal of personalized medicine, 8(1), 1–22. [Google Scholar]
  77. Ren, J., Ding, L., Zhang, D., Shi, G., Xu, Q., Shen, S., Wang, Y., & Wang, T. (2019). Carcinoma-associated fibroblast-derived exosomes regulate tumor progression of hepatocellular carcinoma via miR-200a-3p/Sec23a signaling. Journal of hematology & oncology, 12(1), 1–14. [CrossRef] [PubMed] [Google Scholar]
  78. Ridder, K., Keller, S., Dams, M., Rupp, A. K., Schlaudraff, J., Del Turco, D., Starmann, J., Macas, J., Karpova, D., Devraj, K., Depboylu, C., Landfried, B., Arnold, B., Plate, K. H., Höglinger, G. U., Sültmann, H., Altevogt, P., & Momma, S. (2014). Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation. PLoS biology, 12(6), e1001874. [CrossRef] [PubMed] [Google Scholar]
  79. Sauter, E. R. (2013). Exosome and microvesicle-mediated cancer detection and monitoring: prospects and limitations. Diagnostic cytopathology, 41(12), 1065–1070. [Google Scholar]
  80. Shao, Y., Chen, T., Zheng, X., Yang, S., Xu, K., Chen, X., & Xu, F. (2018). Colorectal cancer-derived small extracellular vesicles establish an inflammatory premetastatic niche in liver metastasis. Carcinogenesis, 39(11), 1368–1379. [CrossRef] [PubMed] [Google Scholar]
  81. Simpson, R. J., & Mathivanan, S. (2012). Extracellular microvesicles: the need for internationally recognised nomenclature and stringent purification criteria. Journal of proteomics and bioinformatics, 5(4), i–ii. [CrossRef] [Google Scholar]
  82. Skotland, T., & Sandvig, K. (2019). Transport of nanoparticles across the endothelial cell barrier. Nano today, 25, 85–96. [CrossRef] [PubMed] [Google Scholar]
  83. Soung, Y. H., Ford, S., Zhang, V., Chung, J., & Exosomes in Cancer Diagnostics. (2017). Current translational geriatrics and experimental gerontology reports, 6(2), 89–94. [Google Scholar]
  84. Syn, N. L., Wang, L., Chow, E. K., Lim, C. T., & Goh, B. C. (2016). Exosomes in cancer nanomedicine and immunotherapy: prospects and challenges. Trends in biotechnology, 34(12), 983–995. [CrossRef] [PubMed] [Google Scholar]
  85. Théry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin-Smith, G. K., Ayre, D. C., Bach, J. M., Bachurski, D., Baharvand, H., Balaj, L., Baldacchino, S., Bauer, N. N., Baxter, A. A., … Zuba-Surma, E. K. (2018). Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. Journal of extracellular vesicles, 7(1), 1535750. [CrossRef] [PubMed] [Google Scholar]
  86. Tkach, M., & Théry, C. (2016). Communication by extracellular vesicles: where we are and where we need to go. Cell, 164(6), 1226–1232. [CrossRef] [PubMed] [Google Scholar]
  87. Vader, P., Mol, E. A., Pasterkamp, G., & Schiffelers, R. M. (2016). Extracellular vesicles for drug delivery. Advanced drug delivery reviews, 106, 148–156. [CrossRef] [PubMed] [Google Scholar]
  88. Vagner, T., Spinelli, C., Minciacchi, V. R., Balaj, L., Zandian, M., Conley, A., Zijlstra, A., Freeman, M. R., Demichelis, F., & De Carvalho, D. D. (2018). Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma. Journal of extracellular vesicles, 7(1), 1505403. [CrossRef] [PubMed] [Google Scholar]
  89. Wang, C., & Wang, M. (2019). Exosomes released by hepatocarcinoma cells endow adipocytes with tumor-promoting properties. Journal of hematology & oncology, 12(1), 1–12. [CrossRef] [PubMed] [Google Scholar]
  90. Wu, Y., Deng, W., McGinley, E. C., Klinke, D. J., & Melanoma exosomes deliver a complex biological payload that upregulates PTPN11 to suppress T lymphocyte function. (2019). Pigment cell & melanoma research, 32(5), 627–638 [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.